Migration of intradermally injected quantum dots to sentinel organs in mice.
Topical exposure to nanoscale materials is likely from a variety of sources including sunscreens and cosmetics. Because the in vivo disposition of nanoscale materials is not well understood, we have evaluated the distribution of quantum dots (QDs) following intradermal injection into female SKH-1 hairless mice as a model system for determining tissue localization following intradermal infiltration. The QD (CdSe core, CdS capped, poly[ethylene glycol] coated, 37 nm diameter, 621 nm fluorescence emission) were injected intradermally (ID) on the right dorsal flank. Within minutes following intradermal injection, the highly UV fluorescent QD could be observed moving from the injection sites apparently through the lymphatic duct system to regional lymph nodes. Residual fluorescent QD remained at the site of injection until necropsy at 24 h. Quantification of cadmium and selenium levels after 0, 4, 8, 12, or 24 h in multiple tissues, using inductively coupled plasma mass spectrometry (ICP-MS), showed a time-dependent loss of cadmium from the injection site, and accumulation in the liver, regional draining lymph nodes, kidney, spleen, and hepatic lymph node. Fluorescence microscopy corroborated the ICP-MS results regarding the tissue distribution of QD. The results indicated that (1) ID injected nanoscale QD remained as a deposit in skin and penetrated the surrounding viable subcutis, (2) QD were distributed to draining lymph nodes through the sc lymphatics and to the liver and other organs, and (3) sentinel organs are effective locations for monitoring transdermal penetration of nanoscale materials into animals.
Gopee
Neera V
NV
National Center for Toxicological Research, U.S Food and Drug Administration, Jefferson, Arkansas 72079, USA.
Roberts
Dean W
DW
Webb
Peggy
P
Cozart
Christy R
CR
Siitonen
Paul H
PH
Warbritton
Alan R
AR
Yu
William W
WW
Colvin
Vicki L
VL
Walker
Nigel J
NJ
Howard
Paul C
PC
D000818:Animals; D002104:Cadmium / Q000008:administration & dosage / Q000493:pharmacokinetics; D005260:Female; D007271:Injections, Intradermal; D013058:Mass Spectrometry; D051379:Mice; D008812:Mice, Hairless; D008856:Microscopy, Fluorescence; D045663:Quantum Dots; D012643:Selenium / Q000008:administration & dosage / Q000493:pharmacokinetics; D012995:Solubility; D013056:Spectrophotometry, Ultraviolet; D019265:Spectroscopy, Near-Infrared; D014018:Tissue Distribution
D002104:Cadmium; D012643:Selenium